These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
702 related items for PubMed ID: 15663717
1. Epidemiology of blood donors in Japan, positive for hepatitis B virus and hepatitis C virus by nucleic acid amplification testing. Murokawa H, Yoshikawa A, Ohnuma H, Iwata A, Katoh N, Miyamoto M, Mine H, Emura H, Tadokoro K, Japanese Red Cross NAT Screening Research Group. Vox Sang; 2005 Jan; 88(1):10-6. PubMed ID: 15663717 [Abstract] [Full Text] [Related]
2. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey. Velati C, Romanò L, Fomiatti L, Baruffi L, Zanetti AR, SIMTI Research Group. Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163 [Abstract] [Full Text] [Related]
3. HBV NAT positive [corrected] blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA. Yoshikawa A, Gotanda Y, Itabashi M, Minegishi K, Kanemitsu K, Nishioka K, Japanese Red Cross NAT Screening Research Group. Vox Sang; 2005 Feb; 88(2):77-86. PubMed ID: 15720604 [Abstract] [Full Text] [Related]
5. Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors. Japanese Red Cross NAT Screening Research GroupJapanese Red Cross Plasma Fractionation Center, Tokyo 105-0013, Japan.. Jpn J Infect Dis; 2000 Jun; 53(3):116-23. PubMed ID: 10957709 [Abstract] [Full Text] [Related]
6. Age- and gender-specific distributions of hepatitis B virus (HBV) genotypes in Japanese HBV-positive blood donors. Yoshikawa A, Gotanda Y, Suzuki Y, Tanaka M, Matsukura H, Shiraishi T, Matsubayashi K, Kon E, Suzuki K, Yugi H, Japanese Red Cross HBV Genotype Research Group. Transfusion; 2009 Jul; 49(7):1314-20. PubMed ID: 19389027 [Abstract] [Full Text] [Related]
7. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus. Li L, Chen PJ, Chen MH, Chak KF, Lin KS, Tsai SJ. Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856 [Abstract] [Full Text] [Related]
9. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, Le Roux M, Kuun E, Gulube S, Reddy R. Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474 [Abstract] [Full Text] [Related]
10. Status of NAT screening for HCV, HIV and HBV: experience in Japan. Tomono T, Murokawa H, Minegishi K, Yamanaka R, Lizuka HY, Miyamoto M, Satoh S, Nakahira S, Murozuka T, Emura H, Doi Y, Mine H, Yokoyama S, Ohnuma H, Tanaka T, Yoshikawa A, Nishioka K, Japanese Red Cross NAT Screening Research Group. Dev Biol (Basel); 2002 Jun; 108():29-39. PubMed ID: 12220140 [Abstract] [Full Text] [Related]
15. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test. Kleinman SH, Strong DM, Tegtmeier GG, Holland PV, Gorlin JB, Cousins C, Chiacchierini RP, Pietrelli LA. Transfusion; 2005 Aug; 45(8):1247-57. PubMed ID: 16078909 [Abstract] [Full Text] [Related]
16. Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations. Koppelman MH, Assal A, Chudy M, Torres P, de Villaescusa RG, Reesink HW, Lelie PN, Cuypers HT. Transfusion; 2005 Aug; 45(8):1258-66. PubMed ID: 16078910 [Abstract] [Full Text] [Related]
17. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus. Hourfar MK, Jork C, Schottstedt V, Weber-Schehl M, Brixner V, Busch MP, Geusendam G, Gubbe K, Mahnhardt C, Mayr-Wohlfart U, Pichl L, Roth WK, Schmidt M, Seifried E, Wright DJ, German Red Cross NAT Study Group. Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173 [Abstract] [Full Text] [Related]
18. Molecular epidemiology of hepatitis viruses and genotypic distribution of hepatitis B and C viruses in Harbin, China. Ding X, Gu H, Zhong ZH, Zilong X, Tran HT, Iwaki Y, Li TC, Sata T, Abe K. Jpn J Infect Dis; 2003 Feb; 56(1):19-22. PubMed ID: 12711821 [Abstract] [Full Text] [Related]
19. First case of hepatitis C virus transmission by a red blood cell concentrate after introduction of nucleic acid amplification technique screening in Germany: a comparative study with various assays. Kretzschmar E, Chudy M, Nübling CM, Ross RS, Kruse F, Trobisch H. Vox Sang; 2007 May; 92(4):297-301. PubMed ID: 17456153 [Abstract] [Full Text] [Related]
20. The hepatitis C virus genotype and subtype frequency in hepatitis C virus RNA-positive, hepatitis C virus antibody-negative blood donors identified in the nucleic acid test screening program in Poland. Brojer E, Gronowska A, Medyńska J, Grabarczyk P, Mikulska M, Letowska M, Kryczka W, Gietka A. Transfusion; 2004 Dec; 44(12):1706-10. PubMed ID: 15584984 [Abstract] [Full Text] [Related] Page: [Next] [New Search]